Provided by Tiger Trade Technology Pte. Ltd.

IceCure Medical Ltd.

1.15
-0.1200-9.45%
Post-market: 1.14-0.0100-0.87%19:59 EDT
Volume:355.46K
Turnover:432.31K
Market Cap:3.94M
PE:-0.17
High:1.30
Open:1.29
Low:1.15
Close:1.27
52wk High:30.30
52wk Low:1.09
Shares:3.43M
Float Shares:2.20M
Volume Ratio:1.19
T/O Rate:16.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.6592
EPS(LYR):-7.1047
ROE:-228.31%
ROA:-73.88%
PB:0.33
PE(LYR):-0.16

Loading ...

BUZZ-IceCure on track for biggest one-day rise as FDA-cleared breast tumor treatment gains traction in U.S.

Reuters
·
Jun 17

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:54 AM

Reuters
·
Jun 17

IceCure reports 70% growth in active US commercial install base after FDA clearance for breast cancer cryoablation

Reuters
·
Jun 17

Icecure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance

THOMSON REUTERS
·
Jun 17

Icecure Medical Ltd trading halted, news pending

TIPRANKS
·
Jun 04

IceCure Medical Executes 1-for-30 Reverse Stock Split to Meet Nasdaq Listing Rules

Deep News
·
Jun 03

IceCure Medical announces 1-for-30 reverse share split to regain Nasdaq compliance

Reuters
·
Jun 02

Icecure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance

THOMSON REUTERS
·
Jun 02

Icecure Medical Earnings Call Highlights Growth Momentum

TIPRANKS
·
May 20

IceCure Showcases Strong ProSense® Cryoablation Data and Surge in Clinical Interest at ECIO 2026

TIPRANKS
·
May 19

IceCure ProSense kidney cancer trial shows 89.4% recurrence-free rate at 4 years

Reuters
·
May 19

IceCure Medical CFO Meir Peleg files initial beneficial ownership statement

Reuters
·
May 18

IceCure Medical Is Maintained at Buy by Maxim Group

Dow Jones
·
May 15

IceCure Medical price target lowered to $1 from $3 at Maxim

TIPRANKS
·
May 14

Icecure Granted 180-Day Extension By Nasdaq To Regain Compliance With Minimum Bid Requirement

Reuters
·
May 14

IceCure Medical Wins Nasdaq Extension to Restore Minimum Bid Compliance

TIPRANKS
·
May 14

IceCure wins Nasdaq extension to regain $1 minimum bid compliance by Nov. 9, 2026

Reuters
·
May 14

Icecure Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Requirement

THOMSON REUTERS
·
May 14

Analysts Offer Insights on Healthcare Companies: Icecure Medical (ICCM) and Upstream Bio, Inc. (UPB)

TIPRANKS
·
May 14

Icecure Medical Ltd reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12